{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:32:58Z","timestamp":1788449578276,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2022B1515230004"],"award-info":[{"award-number":["2022B1515230004"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82071416 and Grant No. U25A2059"],"award-info":[{"award-number":["No. 82071416 and Grant No. U25A2059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xinjiang Uygur Autonomous Region Key Research and Development Program","award":["2022B1515230004"],"award-info":[{"award-number":["2022B1515230004"]}]},{"name":"Guangzhou Municipal Key Research and Development Program","award":["2023B03J0631"],"award-info":[{"award-number":["2023B03J0631"]}]},{"name":"Guangzhou Municipal Science and Technology Bureau, 2024 Basic Research Program of City\u2013University (Hospital) Joint Funding \"Dengfeng Hospital\"","award":["2024A03J1214"],"award-info":[{"award-number":["2024A03J1214"]}]},{"name":"Clinical High-Tech Project of Guangzhou Municipal Health Commission","award":["2026C-GX009"],"award-info":[{"award-number":["2026C-GX009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02322-x","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:04:15Z","timestamp":1778684655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Age-dependent peripheral dissemination of \u03b1-synuclein seeds: mechanistic basis for blood-based early detection of Parkinson\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Yaoyun","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengxu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Quan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"6645","key":"2322_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG et al (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"1","key":"2322_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40035-024-00449-2","volume":"13","author":"Y Kuang","year":"2024","unstructured":"Kuang Y et al (2024) alpha-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation. Transl Neurodegener 13(1):56","journal-title":"Transl Neurodegener"},{"issue":"2","key":"2322_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M et al (2017) Development of a Biochemical Diagnosis of Parkinson Disease by Detection of alpha-Synuclein Misfolded Aggregates in Cerebrospinal Fluid. JAMA Neurol 74(2):163\u2013172","journal-title":"JAMA Neurol"},{"issue":"7","key":"2322_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S1474-4422(25)00157-7","volume":"24","author":"CD Orru","year":"2025","unstructured":"Orru CD et al (2025) Diagnostic and prognostic value of alpha-synuclein seed amplification assay kinetic measures in Parkinson\u2019s disease: a longitudinal cohort study. Lancet Neurol 24(7):580\u2013590","journal-title":"Lancet Neurol"},{"issue":"2","key":"2322_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi R et al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17(2):175\u2013178","journal-title":"Nat Med"},{"key":"2322_CR6","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L et al (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575","journal-title":"Nat Commun"},{"issue":"1","key":"2322_CR7","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1038\/s41467-021-23682-z","volume":"12","author":"B Tanudjojo","year":"2021","unstructured":"Tanudjojo B et al (2021) Phenotypic manifestation of alpha-synuclein strains derived from Parkinson\u2019s disease and multiple system atrophy in human dopaminergic neurons. Nat Commun 12(1):3817","journal-title":"Nat Commun"},{"issue":"1","key":"2322_CR8","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Strohaker","year":"2019","unstructured":"Strohaker T et al (2019) Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts. Nat Commun 10(1):5535","journal-title":"Nat Commun"},{"issue":"1","key":"2322_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41531-024-00738-7","volume":"10","author":"Y Kuang","year":"2024","unstructured":"Kuang Y et al (2024) A skin-specific alpha-Synuclein seeding amplification assay for diagnosing Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):129","journal-title":"NPJ Parkinsons Dis"},{"key":"2322_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","volume":"8","author":"CMG De Luca","year":"2019","unstructured":"De Luca CMG et al (2019) Efficient RT-QuIC seeding activity for alpha-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Transl Neurodegener 8:24","journal-title":"Transl Neurodegener"},{"issue":"1","key":"2322_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40035-024-00426-9","volume":"13","author":"H Mao","year":"2024","unstructured":"Mao H et al (2024) Ultrasensitive detection of aggregated alpha-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson\u2019s disease. Transl Neurodegener 13(1):35","journal-title":"Transl Neurodegener"},{"issue":"1","key":"2322_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo MJ et al (2021) High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. Acta Neuropathol Commun 9(1):179","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"2322_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/mds.29329","volume":"38","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L et al (2023) Accurate Detection of alpha-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson\u2019s Disease in the DeNovo Parkinson (DeNoPa) Cohort. Mov Disord 38(4):567\u2013578","journal-title":"Mov Disord"},{"issue":"1","key":"2322_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41531-022-00431-7","volume":"8","author":"C Xiang","year":"2022","unstructured":"Xiang C et al (2022) A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):165","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"2322_CR15","first-page":"1","volume":"78","author":"Z Wang","year":"2020","unstructured":"Wang Z et al (2020) Skin alpha-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol 78(1):1\u201311","journal-title":"JAMA Neurol"},{"issue":"12","key":"2322_CR16","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1111\/ene.16041","volume":"30","author":"Y Zheng","year":"2023","unstructured":"Zheng Y et al (2023) Comparison of biospecimens for alpha-synuclein seed amplification assays in Parkinson\u2019s disease: A systematic review and network meta-analysis. Eur J Neurol 30(12):3949\u20133967","journal-title":"Eur J Neurol"},{"issue":"5","key":"2322_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00415-025-12978-5","volume":"272","author":"Y Zhao","year":"2025","unstructured":"Zhao Y et al (2025) Skin alpha-synuclein assays in diagnosing Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol 272(5):326","journal-title":"J Neurol"},{"issue":"1","key":"2322_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-025-00488-3","volume":"14","author":"Y Kuang","year":"2025","unstructured":"Kuang Y et al (2025) Enhanced serum-based seed amplification assay for detecting propagative alpha-synuclein seeds in Parkinson\u2019s disease. Transl Neurodegener 14(1):24","journal-title":"Transl Neurodegener"},{"issue":"1","key":"2322_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40478-024-01873-1","volume":"12","author":"Z Wang","year":"2024","unstructured":"Wang Z et al (2024) A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson\u2019s disease. Acta Neuropathol Commun 12(1):167","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"2322_CR20","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi A et al (2023) Propagative alpha-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 29(6):1448\u20131455","journal-title":"Nat Med"},{"issue":"22","key":"2322_CR21","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/WNL.0000000000003989","volume":"88","author":"E Antelmi","year":"2017","unstructured":"Antelmi E et al (2017) Skin nerve phosphorylated alpha-synuclein deposits in idiopathic REM sleep behavior disorder. Neurology 88(22):2128\u20132131","journal-title":"Neurology"},{"issue":"3","key":"2322_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","volume":"20","author":"A Iranzo","year":"2021","unstructured":"Iranzo A et al (2021) Detection of alpha-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol 20(3):203\u2013212","journal-title":"Lancet Neurol"},{"key":"2322_CR23","doi-asserted-by":"crossref","unstructured":"Iranzo A et al (2023) Misfolded alpha-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder. Neurology, 100(18): p. e1944-e1954.","DOI":"10.1212\/WNL.0000000000207147"},{"issue":"9","key":"2322_CR24","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM (2014) Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9(9):2135\u20132146","journal-title":"Nat Protoc"},{"issue":"51","key":"2322_CR25","doi-asserted-by":"publisher","first-page":"e2401552","DOI":"10.1002\/smll.202401552","volume":"20","author":"H Mao","year":"2024","unstructured":"Mao H et al (2024) Optimal Preservation of PFFs in Glycerol Enhances Suitability for Modeling Parkinson\u2019s Disease. Small 20(51):e2401552","journal-title":"Small"},{"issue":"8","key":"2322_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","volume":"14","author":"CH Schenck","year":"2013","unstructured":"Schenck CH et al (2013) Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy\u2013a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med 14(8):795\u2013806","journal-title":"Sleep Med"},{"key":"2322_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-227X-12-13","volume":"12","author":"O Calcagnile","year":"2012","unstructured":"Calcagnile O, Unden L, Unden J (2012) Clinical validation of S100B use in management of mild head injury. BMC Emerg Med 12:13","journal-title":"BMC Emerg Med"},{"issue":"1","key":"2322_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41531-024-00640-2","volume":"10","author":"T Thi Lai","year":"2024","unstructured":"Thi Lai T et al (2024) Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson\u2019s disease mouse model. NPJ Parkinsons Dis 10(1):32","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"2322_CR29","doi-asserted-by":"publisher","first-page":"e12024","DOI":"10.1002\/jev2.12024","volume":"10","author":"Y Kuang","year":"2020","unstructured":"Kuang Y et al (2020) Adipose-derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR-25. J Extracell Vesicles 10(1):e12024","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"2322_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrn3039","volume":"12","author":"TJ Collier","year":"2011","unstructured":"Collier TJ, Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates. Nat Rev Neurosci 12(6):359\u2013366","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"2322_CR31","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/brain\/awab061","volume":"144","author":"N Van Den Berge","year":"2021","unstructured":"Van Den Berge N et al (2021) Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats. Brain 144(6):1853\u20131868","journal-title":"Brain"},{"key":"2322_CR32","doi-asserted-by":"crossref","unstructured":"Verma DK et al (2021) Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson\u2019s Disease Models. Cells, 10(7)","DOI":"10.3390\/cells10071694"},{"issue":"1","key":"2322_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-024-01816-8","volume":"10","author":"B Hong","year":"2024","unstructured":"Hong B et al (2024) Glial senescence enhances alpha-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction. Cell Death Discov 10(1):50","journal-title":"Cell Death Discov"},{"issue":"1","key":"2322_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41467-018-08130-9","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z et al (2019) Early preclinical detection of prions in the skin of prion-infected animals. Nat Commun 10(1):247","journal-title":"Nat Commun"},{"issue":"9","key":"2322_CR35","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL et al (2016) Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med 213(9):1759\u20131778","journal-title":"J Exp Med"},{"key":"2322_CR36","doi-asserted-by":"publisher","first-page":"715190","DOI":"10.3389\/fnint.2021.715190","volume":"15","author":"TT Lai","year":"2021","unstructured":"Lai TT et al (2021) Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson\u2019s Disease Mouse Model. Front Integr Neurosci 15:715190","journal-title":"Front Integr Neurosci"},{"issue":"1","key":"2322_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-024-03108-5","volume":"21","author":"AC Stoll","year":"2024","unstructured":"Stoll AC et al (2024) Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition. J Neuroinflammation 21(1):108","journal-title":"J Neuroinflammation"},{"issue":"11","key":"2322_CR38","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I (2021) The blood-brain barrier in systemic infection and inflammation. Cell Mol Immunol 18(11):2489\u20132501","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"2322_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Tredici KD, Braak H (2007) Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33(6):599\u2013614","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"2322_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/mds.27670","volume":"34","author":"RB Postuma","year":"2019","unstructured":"Postuma RB, Berg D (2019) Prodromal Parkinson\u2019s Disease: The Decade Past, the Decade to Come. Mov Disord 34(5):665\u2013675","journal-title":"Mov Disord"},{"issue":"1","key":"2322_CR41","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41598-020-80889-8","volume":"11","author":"O Elabi","year":"2021","unstructured":"Elabi O et al (2021) Human alpha-synuclein overexpression in a mouse model of Parkinson\u2019s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation. Sci Rep 11(1):1120","journal-title":"Sci Rep"},{"issue":"1","key":"2322_CR42","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","volume":"10","author":"K Haruwaka","year":"2019","unstructured":"Haruwaka K et al (2019) Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Nat Commun 10(1):5816","journal-title":"Nat Commun"},{"issue":"1suppl","key":"2322_CR43","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1177\/0271678X20951995","volume":"40","author":"PT Ronaldson","year":"2020","unstructured":"Ronaldson PT, Davis TP (2020) Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity. J Cereb Blood Flow Metab 40(1suppl):S6\u2013S24","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"2322_CR44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00401-015-1524-y","volume":"131","author":"N Dudvarski Stankovic","year":"2016","unstructured":"Dudvarski Stankovic N et al (2016) Microglia-blood vessel interactions: a double-edged sword in brain pathologies. Acta Neuropathol 131(3):347\u2013363","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2322_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M et al (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140(1):49\u201362","journal-title":"Acta Neuropathol"},{"issue":"9","key":"2322_CR46","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/brain\/awac115","volume":"145","author":"A Kluge","year":"2022","unstructured":"Kluge A et al (2022) Detection of neuron-derived pathological alpha-synuclein in blood. Brain 145(9):3058\u20133071","journal-title":"Brain"},{"issue":"22","key":"2322_CR47","first-page":"2109","volume":"248","author":"V Gayger-Dias","year":"2023","unstructured":"Gayger-Dias V et al (2023) How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury. Exp Biol Med (Maywood) 248(22):2109\u20132119","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"2322_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40279-013-0119-9","volume":"44","author":"SX Koh","year":"2014","unstructured":"Koh SX, Lee JK (2014) S100B as a marker for brain damage and blood-brain barrier disruption following exercise. Sports Med 1004(3):369\u2013385","journal-title":"Sports Med"},{"issue":"Pt 11","key":"2322_CR49","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","volume":"135","author":"K Sathe","year":"2012","unstructured":"Sathe K et al (2012) S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain 135(Pt 11):3336\u20133347","journal-title":"Brain"},{"key":"2322_CR50","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fnagi.2020.00156","volume":"12","author":"E Papuc","year":"2020","unstructured":"Papuc E, Rejdak K (2020) Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson\u2019s Disease. Front Aging Neurosci 12:156","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2322_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jnc.14574","volume":"148","author":"F Michetti","year":"2019","unstructured":"Michetti F et al (2019) The S100B story: from biomarker to active factor in neural injury. J Neurochem 148(2):168\u2013187","journal-title":"J Neurochem"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02322-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02322-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:04:21Z","timestamp":1783469061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02322-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2322"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02322-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures adhered to institutional animal care guidelines and were ethically approved by the Animal Ethics Committee of Guangzhou Medical University. The human study was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (Approval No. ES-2024-216-01), and all participants provided written informed consent prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}